logo

For the Inventor, By the Inventor

Ahmedabad, India

Cadila Pharmaceuticals Limited


USPTO Granted Patents = 19

% Expired Patents = 52.6



Forward Citations = 30

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Bakulesh Mafatlal Khamar (18 out of 19 patents)

silverMedal Indravadan Ambalal Modi (12 out of 13 patents)

bronzeMedal Rajiv Indravadan Modi (10 out of 11 patents)

4.  Nirav Manojkumar Desai (6 out of 6 patents)

5.  Chandreshwar Prasad Shukla (3 out of 3 patents)

6.  Avani Devenbhai Darji (2 out of 2 patents)

7.  Chandan Hardhan Singh (2 out of 2 patents)

8.  Ashish Premkumar Gogia (2 out of 2 patents)

9.  Vandana Bharat Patravale (2 out of 2 patents)

10.  Ritu Nitin Laddha (2 out of 2 patents)

11.  Prasanta Kumar Ghosh (2 out of 2 patents)

12.  Satinder Singh (1 out of 1 patent)

13.  Kumud Kumar Padhee (1 out of 1 patent)

14.  Nilamkumari Somalal Patel (1 out of 1 patent)

15.  Amit Mukharya (1 out of 1 patent)


19 patents:

1. 11219674 - Therapeutic cancer vaccine (2022-01-11),
2. 10335472 - Therapeutic cancer vaccine (2019-07-02),
3. 9795659 - Pharmaceutical composition of killed cells with substantially retained immunogenicity (2017-10-24),
4. 9789187 - Stable pharmaceutical composition for atherosclerosis (2017-10-17),
5. 9714275 - Cancer antigen (2017-07-25),
6. 9708258 - Indole 3-carbinol derivatives (2017-07-18),
7. 9474727 - Pharmaceutical compositions of curcumin (2016-10-25),
8. 9415078 - [object Object] (2016-08-16),
9. 9345683 - Pharmaceutical composition of taxoids (2016-05-24),
10. 9029567 - Hypoglycemic compounds (2015-05-12),
11. 8647643 - Farnesoid-X-receptor antagonist as a vaccine adjuvant (2014-02-11),
12. 8563517 - Dipeptidyl peptidase IV (DP-IV) compounds (2013-10-22),
13. 8333978 - Poly TLR antagonist (2012-12-18),
14. 8277778 - Vaccine adjuvants (2012-10-02),
15. 8153102 - [object Object] (2012-04-10),
Company Overview
Cadila Pharmaceuticals Limited is a prominent player in the global pharmaceutical industry, headquartered in Ahmedabad, India. The company specializes in the development and manufacturing of a wide range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong focus on research and development, Cadila is dedicated to advancing healthcare solutions across various therapeutic areas, including cardiovascular, diabetes, and infectious diseases, while maintaining a commitment to quality and innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cadila Pharmaceuticals Limited USPTO Patent Assignee Logo
19 Patents

#4 in Ahmedabad

#102 in India

#32,663 in the World

Ahmedabad, IN
Ahmedabad, India

Cadila Pharmaceuticals Limited

Forward Citations = 30

27 inventors:

goldMedal Bakulesh Mafatlal Khamar (18 out of 19 patents)

silverMedal Indravadan Ambalal Modi (12 out of 13 patents)

bronzeMedal Rajiv Indravadan Modi (10 out of 11 patents)

4.  Nirav Manojkumar Desai (6 out of 6 patents)

5.  Chandreshwar Prasad Shukla (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cadila Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/cadila-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…